N/A
Completed N=87
Effects of Narratives on Demand for Low and High Ventilated Cigarettes and Substitution for Alternative Products
Cigarette Smoking
Source: ClinicalTrials.gov NCT05487625 ↗
Enrolled (actual)
87
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcomePrimary: Nicotine/Tobacco Products Substitution Intercept — 16.4; 94.2; 47.8; 56.0 Mg of Nicotine purchased
Summary
This study will investigate the effects of narratives on demand for low and high ventilated cigarettes and substitution for alternative products in the Experimental Tobacco Marketplace.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Nicotine/Tobacco Products Substitution Intercept |
16.4; 94.2; 47.8; 56.0; 12.1; 67.4 | — |
| PRIMARY Cigarette Demand Intensity q0 |
2509.951; 2446.043; 2002.901; 1226.371; 1389.097; 1201.065 | — |
| PRIMARY Nicotine/Tobacco Products Substitution Slope |
13.24; -10.33; 1.96; 1.65; 11.50; -4.26 | — |
| PRIMARY Cigarette Demand Elasticity Alpha |
0.0001184530; 0.0001866522; 0.0006728454; -0.004862780; 0.003933976; 0.002001107 | — |
Eligibility Criteria
Inclusion Criteria
- Provide informed consent
- Be at least 21 years of age or older
- Provide a breath sample for measuring carbon monoxide (CO ≥ 8 ppm)
- Stable tobacco use patterns for at least three months
- Be willing to sample the study cigarettes (high- and low-ventilated cigarettes)
- Report smoking a high-ventilated cigarette (>= 20% ventilation)
- Report smoking at least 10 cigarettes per day
Exclusion Criteria
- Have plans to move out of the area
- Have a serious or unstable physical or mental health condition
- Taking a tobacco cessation medication or medication that interferes with nicotine metabolism, motivation or reinforcement
- Report concrete, immediate plans to alter/quit using their usual nicotine products at the beginning of the study
Note: Participants may be withdrawn from the study after providing consent if they submit an invalid breath sample (CO ≥ 8 ppm).
Data sourced from ClinicalTrials.gov (NCT05487625). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.